This Article Order Full text via Infotrieve Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Holland, J. P. Articles by Bell, B. A. Search for Related Content PubMed PubMed Citation Articles by Holland, J. P. Articles by Bell, B. A.

Stroke, Vol 25, 2055-2058, Copyright © 1994 by American Heart Association

ARTICLES

Calcitonin gene-related peptide reduces brain injury in a rat model of focal cerebral ischemia

JP Holland, SG Sydserff, WA Taylor and BA Bell
Division of Clinical Neuroscience, St George's Hospital Medical School, Atkinson Morley's Hospital, Wimbledon, London, UK.

BACKGROUND AND PURPOSE: Calcitonin gene-related peptide is an endogenous vasodilating neuropeptide with a dense concentration in the trigeminocerebrovascular system. It is hypothesized that depletion of this peptide contributes to delayed cerebral ischemia after subarachnoid hemorrhage and that an exogenous supply of calcitonin gene- related peptide will augment ischemic cerebral blood flow and reduce neuronal injury. METHODS: In this study we have investigated the effect of an intravenous infusion of calcitonin gene-related peptide (100 ng/kg per minute), started 1 hour before and continued throughout 4 hours of focal cerebral ischemia, on cerebral blood flow and the volume of brain injury in a rat model of middle cerebral artery occlusion. RESULTS: Calcitonin gene-related peptide produces a significant improvement in ischemic cerebral blood flow (32 +/- 2 compared with 13 +/- 2 mL/100 g per minute in the controls; t = 6.92, P < .0001) with a concomitant reduction in the volume of ischemic brain injury (102 +/- 22 compared with 234 +/- 19 mm3; t = 4.47, P < .001). CONCLUSIONS: These findings lend support for the potential use of this peptide in the prophylactic treatment of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.

This article has been cited by other articles:

				R. Veltkamp, F. Domoki, F. Bari, D. W. Busija, and W. G. Mayhan Potassium Channel Activators Protect the N-Methyl-D-Aspartate–Induced Cerebral Vascular Dilation After Combined Hypoxia and Ischemia in Piglets • Editorial Comment Stroke, April 1, 1998; 29(4): 837 - 843. [Abstract] [Full Text] [PDF]

				M. G. Lang, R. Paterno, F. M. Faraci, D. D. Heistad, and J. R. Kirsch Mechanisms of Adrenomedullin-Induced Dilatation of Cerebral Arterioles Stroke, January 1, 1997; 28(1): 181 - 185. [Abstract] [Full Text]

				T. M. Louis, W. Meng, F. Bari, R. A. Errico, and D. W. Busija Ischemia Reduces CGRP-Induced Cerebral Vascular Dilation in Piglets Stroke, January 1, 1996; 27(1): 134 - 139. [Abstract] [Full Text]